Sahajanand Medi, a company in the Medical Equipment & Supplies industry, reported revenue of ₹373 crore and net profit of ₹26 crore for the September 2026 quarter.
Sahajanand Medi (NSE: SMT) closed at ₹527.60 on 20 Nov 2026. Its market capitalisation is ₹5,363 crore and it trades at 74.7 times earnings.
Sahajanand Medical Technologies Ltd (SMT) develops and manufactures Class III /Class C- D cardiovascular devices used in vascular and structural-heart interventions. Its main products include coronary stents and balloons, TAVI heart valves and congenital-heart occluders. It sold products across 77 countries in FY26.
Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.